SCHEMBL16245609

SCHEMBL16245609

CC(C)(C)OC(=O)NCCCn1cc(Nc2ncc3ncn(-c4ccc(OCCCC(=O)O)cc4)c3n2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 8/20 0.42
▸ HDAC6 Q9UBN7 8/20 0.42
▸ HDAC1 Q13547 2/20 0.42
▸ JAK3 P52333 2/20 0.42
▸ JAK1 P23458 1/20 0.42
▸ TYK2 P29597 1/20 0.42
▸ RPS6KA3 P51812 3/20 0.41
▸ EIF2AK4 Q9P2K8 2/20 0.41
▸ WEE1 P30291 3/20 0.40
▸ SRC P12931 3/20 0.40
▸ ITK Q08881 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC9 Q9UKV0 1/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16245556 0.92 JAK2 (0.44) JAK2HDAC6HDAC1JAK3JAK1
SCHEMBL16264888 0.90 ITK (0.48) JAK3RPS6KA3WEE1SRCITK
SCHEMBL17821176 0.88 EIF2AK4 (0.55) JAK2HDAC6HDAC1JAK3JAK1
SCHEMBL16245539 0.87 ITK (0.47) JAK3RPS6KA3WEE1SRCITK
SCHEMBL16245554 0.86 RPS6KA3 (0.51) JAK3RPS6KA3WEE1SRCITK
SCHEMBL16264847 0.86 JAK2 (0.47) JAK2HDAC6HDAC1JAK3JAK1
SCHEMBL16264861 0.85 EIF2AK4 (0.55) JAK2HDAC6HDAC1JAK3JAK1
Hydrochloric Acid SCHEMBL16245600 0.85 JAK2 (0.46) JAK2HDAC6HDAC1JAK3JAK1
SCHEMBL16245590 0.84 RPS6KA3 (0.50) JAK3RPS6KA3WEE1SRCITK
SCHEMBL16246066 0.83 EIF2AK4 (0.51) JAK3EIF2AK4WEE1SRCITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9861635-B2 Macrocycles as kinase inhibitors MERCK PATENT GMBH (DE) 2018-01-09 — — US disclosed
US-9861635-B2 Macrocycles as kinase inhibitors MERCK PATENT GMBH (DE) 2018-01-09 — — US disclosed
EP-2994471-B1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2017-05-17 — — EP disclosed
EP-2994471-B1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2017-05-17 — — EP disclosed
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2016-06-16 — — US disclosed
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2016-06-16 — — US disclosed
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2016-06-16 — — US disclosed
EP-2994471-A1 MACROCYCLES AS KINASE INHIBITORS Merck Patent GmbH (DE) 2016-03-16 — — EP disclosed
WO-2014180524-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2014-11-13 — — WO disclosed
WO-2014180524-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2014-11-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS EIF2AK4, CDK2, CDK1 JAK2 267/4885HDAC6 1217/4885HDAC1 598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback